Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
EV/CE

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year EV/CE History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/CE(x) 9.52-0.030.06-0.07-0.05

What is the latest EV/CE ratio of MANKIND PHARMA ?

The latest EV/CE ratio of MANKIND PHARMA is 9.52 based on Mar2024 Consolidated results.
Year EV/CE
Mar20249.52
Mar2023-0.03
Mar20220.06
Mar2021-0.07
Mar2020-0.05

How is EV/CE of MANKIND PHARMA Trending?

Years EV/CE % Change
Mar2024 9.52
Positive
Mar2023 -0.03
Negative
Mar2022 0.06
Positive
Mar2021 -0.07
Negative
Mar2020 -0.05 -

Other Financial Ratios of MANKIND PHARMA


Compare EV/CE ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹98,894.0 Cr -4.4% -7.8% 13.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,003.0 Cr -1.6% -4.6% 14.7% Stock Analytics
DIVIS LABORATORIES ₹154,939.0 Cr -1.6% -1.3% 61.6% Stock Analytics
CIPLA ₹117,835.0 Cr 0.1% 1.2% 3.3% Stock Analytics
DR REDDYS LABORATORIES ₹99,787.0 Cr -2.1% -8.7% -2.3% Stock Analytics
ZYDUS LIFESCIENCES ₹90,722.1 Cr -6.5% -9.3% 8.6% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-4.4%

-7.8%

13.3%

SENSEX

-2.5%

-1.4%

6.1%


You may also like the below Video Courses